[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"obesity-maternal\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:obesity-maternal":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,43,69,94],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":4},"100643080","the-application-of-hcg-in-luteal-support-for-frozen-embryo-transfer-in-ovulation-cycle-of-obese-women-100643080",false,"NCT07633002","The Application of HCG in Luteal Support for Frozen Embryo Transfer in Ovulation Cycle of Obese Women","The Application of HCG in the Luteal Support of Frozen Embryo Transfer During Ovulation Cycles in Overweight and Obese Women","Inclusion Criteria:\n\n* Age ≤37 years old ② Prepare the endometrium in the natural cycle\u002Fovulation induction cycle ③ BMI≥24 according to the overweight standard for the Asian population ④ Single blastocyst transfer (including IVF and ICSI-assisted pregnancy) ⑤ At least one frozen blastocyst remaining in the IVF\u002FICSI cycle with a Gardner morphology score of ≥4BC, and the age of the frozen embryo is D5 or D6\n\nExclusion Criteria:\n\n* There is a history of adenomyosis, hydrosalpinx, intrauterine adhesions or untreated submucosal fibroids of the uterus\n\n  * Uterine malformations; ③ The endometrial thickness on the conversion day is less than 7mm, or the cycle was cancelled during the endometrial preparation process before frozen embryo transfer due to the endometrium being less than 7mm in the past.\n\n    * Have a history of the immune system, such as antiphospholipid syndrome\u002Fsystemic lupus erythematosus\u002Frheumatism; ⑤ Diabetic patients who have not been controlled by standardized medication; ⑥ Those who have undergone embryo transfer more than or equal to two times without achieving a live birth ⑦ Those whose embryos to be thawed and thawed are from donated or frozen egg sources, or have undergone two freezing operations",true,"FEMALE","22 Years","37 Years",{"count":21,"type":22},750,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study aims to explore whether the application of low-dose HCG in luteal support can improve the pregnancy outcomes of natural cycle frozen embryo transfer in obese patients",[28],"Obesity, Maternal",[30],"obesity,IVF-ET,Frozen embryo transfer","NOT_YET_RECRUITING","2026-06-03",{"date":34,"type":35},"2026-06-08","ACTUAL",{"date":37,"type":22},"2026-07-01",{"date":39,"type":22},"2027-12-31",{"name":41,"class":42},"The Second Hospital of Shandong University","OTHER",{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":51,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":23,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":68},"100550319","nutrition-optimization-and-community-upliftment-for-postpartum-recovery-100550319","NCT06445530","Nutrition Optimization and Community Upliftment for Postpartum Recovery","Nutrition Optimization and Community Upliftment for Postpartum Recovery: Interventions to Support Healing After Gestational Diabetes","NOURISH-GDM","Inclusion Criteria:\n\n* Age ≥18 years\n* Self-identify as Black or African American\n* Low-income (defined as eligible for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefits)\n* Speak English as a primary language\n* Identify as a primary meal planner\u002Fpreparer\n* Gestational diabetes\n* Gestational age \\>37 weeks\n* Have a BMI \\> 30 (calculated based on chart review of height and weight measurement)\n* Willing to take part in the intervention and data collection procedures through online surveys\n\nExclusion Criteria:\n\n* Mothers who have social support i.e. have family members preparing meals for the mother\n* Mothers who are unlikely to be at the primary residence in the postpartum period\n* Mothers with very specific dietary needs, i.e, food allergies, picky eaters, vegetarian \u002F vegan\n* Mothers whose birth outcome is a stillborn\n* Mothers who have serious mental illness","18 Years",{"count":53,"type":22},40,[25],"The goal of this clinical trial is to better understand how different strategies, timing, and enhancements to medically tailored food delivery will address structural inequities in the food environment, empower communities to sustain behavior change, and ultimately improve postpartum weight control to prevent type 2 diabetes-a potent contributor to disparate mortality among Black women.\n\nThe main aims of the study are:\n\n* To conduct a pilot randomized control trial to test the feasibility, acceptability, and effectiveness of a multi-component Medically Tailored Food (MTF) intervention, Moveable Feast ENHANCED (a hybrid MTF intervention with a patient-activated change from prepared meals to fresh food delivery, customized for postpartum people, culturally customized for engagement and adherence, and food provision for dependents) versus MFeast Usual Care (prepared medically tailored foods only)\n* To test sustainability and scalability.\n\nParticipants will:\n\n* Respond to online surveys (supported by study team members via scheduled phone calls) via REDCap links shared before each study visit at baseline, 3, 6 months post-delivery after the baseline survey.\n* Submit anthropometric data (i.e, weight) and information about laboratory results ( e.g. HgbA1C)",[28,57],"Gestational Diabetes","RECRUITING","2025-09-30",{"date":61,"type":35},"2025-10-03",{"date":63,"type":35},"2025-09-15",{"date":65,"type":22},"2027-06",{"name":67,"class":42},"Johns Hopkins University",1,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":16,"sex":17,"minAge":51,"maxAge":77,"enrollmentInfo":78,"targetDuration":4,"studyType":80,"phases":4,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":68},"100497238","the-microbiome-in-non--obese-pregnancy-and-pregnancy-outcomes-100497238","NCT05754645","The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes","The PROMOTE Study, a Pilot: The Characterization of the Microbiome in Pregnancy and Prediction of Pregnancy Outcomes","PROMOTE","Inclusion Criteria:\n\n* Participation in Predict study\n* Preconceptional women who wish to become pregnant or pregnancy \\\u003C13 weeks of gestational age.\n* BMI \\> 30 kg\u002Fm2 or 18-25 kg\u002Fm2\n* Understanding of Dutch in speaking and reading\n* Willingness to give written informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years and \\> 45 years.\n* ≥13 weeks of gestational age\n* Multiple pregnancy\n* Smoking\n* Gastro-intestinal diseases, heart diseases, liver, pancreas and kidney diseases.\n* Use of antibiotics \\\u003C 2 weeks before sampling\n* Pre-existent diabetes mellitus","45 Years",{"count":79,"type":22},110,"OBSERVATIONAL","This research aims to elucidate an underlying mechanism of maternal obesity induced pregnancy and longterm health complications for mothers and their offspring.",[28,83,84],"Pregnancy Complications","Gut Microbiota","2024-09-12",{"date":87,"type":35},"2024-09-19",{"date":89,"type":35},"2022-07-21",{"date":91,"type":22},"2026-08-21",{"name":93,"class":42},"Erasmus Medical Center",{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":17,"minAge":51,"maxAge":4,"enrollmentInfo":102,"targetDuration":4,"studyType":23,"phases":104,"briefSummary":105,"conditions":106,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":68},"100534616","supporting-lifestyle-changes-after-delivery-100534616","NCT06241144","Supporting Lifestyle Changes After Delivery","Information and Communication Technology -Based Health Behavior Change Support System to Modify Lifestyle After Delivery: Randomized Controlled Intervention Study","STELLA","Inclusion Criteria:\n\n* Pre-pregnancy BMI ≥ 30.0 kg\u002Fm\\^2\n* Smartphone user\n\nExclusion Criteria:\n\n* Eating disorder\n* Severe mental disorder\n* Use of other lifestyle support system or medication\n* Non-Finnish speaker",{"count":103,"type":22},200,[25],"Use of information and communication technology -based health behavior change support system in modifying lifestyle after delivery among women with obesity.",[28,107],"Lifestyle","2024-04-01",{"date":110,"type":35},"2024-04-03",{"date":112,"type":35},"2024-02-09",{"date":114,"type":22},"2032-12-31",{"name":116,"class":42},"Oulu University Hospital"]